Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Core One Labs Inc (OP:CLABF)

0.0950 +0.0544 (+133.99%)
Streaming Delayed Price Updated: 2:59 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,274
Open 0.0950
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0406
Today's Range 0.0950 - 0.0950
52wk Range 0.0260 - 0.1729
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market
Via ACCESSWIRE
Core One Labs’ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment Methods
Via ACCESSWIRE

Performance

YTD
+58.3%
+58.3%
1 Month
+125.7%
+125.7%
3 Month
+46.2%
+46.2%
6 Month
-8.0%
-8.0%
1 Year
-33.7%
-33.7%

More News

Read More
Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's Disease
Via ACCESSWIRE
Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
Via ACCESSWIRE
Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease
Via ACCESSWIRE
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Via Benzinga
Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds
Via Benzinga
Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
Via ACCESSWIRE
Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method
Via ACCESSWIRE
Core One in Talks with Multiple Companies to Supply Psilocybin
Via ACCESSWIRE
Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy
Via ACCESSWIRE
Core One's Awakened Lays The Groundwork For The Large-Scale Production Of Psychedelic Compounds With Synthetic Production Of Psilocin
Via Benzinga
Core One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility
Via ACCESSWIRE
Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin
Via Benzinga
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Via Benzinga
Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases
Via ACCESSWIRE
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Via Benzinga
Core One Labs' Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers
Via ACCESSWIRE
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Via Benzinga
Psychedelic Mushrooms Soon To Be Commercially Produced And Sold In Canada
Via Benzinga
Core One Labs’ Prepares for Commercial Production of API-Grade Psilocybin; Plans Initial Production Run at GMP Facility in January
Via ACCESSWIRE
Core One Labs Takes Next Steps to Prepare for Potential Takeover Opportunities
Via ACCESSWIRE
European University to Fund Core One Labs' Akome Advanced Neurogenesis Stimulation Studies
Via ACCESSWIRE
Core One Labs Nearing GMP Production as Canada’s Province of Alberta Announces Game Changing Legislation
Via ACCESSWIRE
Core One Labs Announces Breakthrough with Proprietary Isolation and Purification Method of Psilocybin from Mushrooms; Prepares Patent Application
Via ACCESSWIRE

Frequently Asked Questions

Is Core One Labs Inc publicly traded?
Yes, Core One Labs Inc is publicly traded.
What exchange does Core One Labs Inc trade on?
Core One Labs Inc trades on the OTC Traded
What is the ticker symbol for Core One Labs Inc?
The ticker symbol for Core One Labs Inc is CLABF on the OTC Traded
What is the current price of Core One Labs Inc?
The current price of Core One Labs Inc is 0.0950
When was Core One Labs Inc last traded?
The last trade of Core One Labs Inc was at 05/08/25 02:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.